John Lechleiter

Lilly CEO elected chairman of United Way Worldwide board

May 14, 2014
Associated Press
United Way Worldwide President and CEO Brian Gallagher said John Lechleiter will help strengthen the not-for-profit network's capacity to meet growing human needs around the world.
More

Lilly CEO got 10-percent pay boost last year

March 24, 2014
J.K. Wall
Lilly CEO John Lechleiter was paid $11.2 million in salary, bonus, stock and perks last year, according to Lilly's proxy statement filed Monday morning. That represented a 10-percent increase over his take in 2012.
More

Lechleiters, Bralys contribute $1M each to United Way

December 19, 2013
J.K. Wall
John Lechleiter, Angela Braly and two other local business leaders have pledged a combined $3 million to United Way of Central Indiana over the next four years. United Way is trying to raise $42.5 million by the end of the year.
More

Lilly's Lechleiter back at helm after health scare

July 8, 2013
Associated Press
Eli Lilly and Co. Chairman and CEO John Lechleiter is back to full-time work after taking a leave in May to have surgery for a dilated aorta, the company announced Monday morning.
More

Lechleiter's surgery to repair heart goes as planned

May 14, 2013
Bloomberg News
Eli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta is functioning as intended, the Indianapolis-based drugmaker said.
More

Lilly CEO: Immigration, tax laws slow innovation

June 23, 2011
Bloomberg News
The U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly & Co. CEO John Lechleiter plans to tell a technology conference Thursday.
More

Lechleiter: After the deluge, we'll be fine

March 16, 2011
J.K. Wall
Eli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly will be just fine after it has sustained the damage of the next three years.
More

Struggling Lilly turns to antidepressant Cymbalta for lift

February 5, 2011
Greg Andrews
Cymbalta racked up $3.5 billion in sales last year, and some analysts say it may approach $5 billion before generic competition arrives in 2013.
More

Lilly awards pay increases to top executives

February 8, 2010
Peter Schnitzler, J.K. Wall
Eli Lilly and Co. CEO John Lechleiter's total compensation increased $4.1 million in 2009.
More

UPDATE: Pipeline challenges force Lilly restructuring moves

September 14, 2009
J.K. Wall
Since John Lechleiter was named CEO 18 months ago, he's bet that Eli Lilly and Co. could face down its looming patent challenges by launching innovative new medicines. Today's announcement of 5,500 job cuts by the end of 2011 and a restructuring of the company's business units ups the ante on that bet, while indicating that it isn't working yet.
More

United Way calling on well-heeled to dig deepRestricted Content

August 10, 2009
Kathleen McLaughlin
After so many years of trying to tap every possible cubicle-dweller for donations, United Way of Central Indiana is putting more effort into the richest veins in the workplace—the folks in corner offices.
More

Eli Lilly CEO, wife give United Way $1M gift

July 28, 2009
Kathleen McLaughlin
Eli Lilly and Co. CEO John Lechleiter and his wife, Sarah, have pledged to give the United Way of Central Indiana a total of $1 million over the next four years as a “challenge to CEOs and other community leaders to step up their giving.”
More

With pharma famine looming, Lilly relying on snack-size dealsRestricted Content

May 4, 2009
J.K. Wall
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year, Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
More

New Lilly CEO called analytical, 'incredibly warm'Restricted Content

December 24, 2007
J.K. Wall
John C. Lechleiter, whom Eli Lilly and Co.'s board voted to replace Sidney Taurel as CEO, is known for getting things done and yet also for being good at analysis and relating to people under him. Taurel will step down at the end of March but remain chairman until the end of 2008.
More
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT